You have no items in your shopping cart.
IFNa1 Reference Antibody
Description
Images & Validation
−| Tested Applications | FC, Kinetics |
|---|---|
| Reactivity | Human, Mouse |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Source/Expression System | CHO Cell |
| Molecular Weight | 144.82 |
| Endotoxin | < 0.001EU/μg,determined by LAL method. |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
|---|---|
| Form/Appearance | Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column. |
| Concentration | 1mg/ml |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−IFNa1 Reference Antibody [orb1805933]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
1 mg, 100 μgIFNa1 Reference Antibody [orb1805903]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
100 μg, 1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

The purity of Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha) is more than 95%, determined by SEC-HPLC.

Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%
Quick Database Links
UniProt Details
−Documents Download
Request a Document
IFNa1 Reference Antibody (orb1817544)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review








